Who
Antonio Bernardino Guimaraes Parada
Director
Company insider
Files Form 4 as: Director, iBio.
In numbers
- Trades disclosed
- 4
- Buys
- 1
- Sells
- 0
- Bought
- $500K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 21 Nov 2024
- Last trade
- 14 Oct 2026
- Last filed
- 15 Oct 2026
Companies traded
Activity over time
1 Jan 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Oct 2026filed 15 Oct 2026 | IBIO iBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —38,000 at $0.00 | filing |
| 20 Nov 2025filed 24 Nov 2025 | IBIO iBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —13,500 at $0.00 | filing |
| 10 Jan 2025filed 13 Jan 2025 | IBIO iBioBiotechnology | SEC FORM 4 Bought | $500K183,823 at $2.72 | filing |
| 21 Nov 2024filed 9 Dec 2024 | IBIO iBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —12,600 at $0.00 | filing |
News
Head to Head Comparison: Myriad Genetics (NASDAQ:MYGN) & iBio (NASDAQ:IBIO)IBIO · themarketsdaily.com · 19 Oct 2026
0 headlines in the last 90 days name Antonio Bernardino Guimaraes Parada; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.